China Animal Healthcare Posts 63.4% Revenue Surge in 1H08 中国动物保健报上半年度收入飙升63.4%

China Animal Healthcare’s revenue for 1H08 increased 63.4% from Rmb103.8m in 1H07 to Rmb169.6m in 1H08. Average selling prices have not fluctuated significantly period-on-period, while demand for the Group’s products has continued to experience strong growth in 2008 as usage of animal drugs has increased across China. The cost of sales of the Group constituted approximately 24.9% and 23.6% of its revenue in 1H08 & 1H07 respectively. The main components of its cost of sales include the cost of raw materials and there were no significant increases in the prices of the raw materials in 2Q08. In line with the sales increase, gross profit surged 60.5% from Rmb79.3m in 1H07 to Rmb127.3m in 1H08.

中国动物保健(China Animal Healthcare)的08财政年度上半年收入从07财政年度上半年的1亿零380万人民币增加了63.4%至 1亿6,960万人民币。同期的平均售价没有太大的波动，而2008年对集团产品的需求则持续强劲增长，因为中国全国各地对动物药品的使用增加。销售成本分别占集团08及07财政年度上半年收入约24.9%及23.6%。销售成本的主要项目包括了原材料成本，而在08财政年度第二季，原材料价格的增幅不大。上半年的总盈利从去年同期的7,930万人民币飙升60.5%至1亿2,730万人民币，后者与销售增长相符。